Loading…
Dr Lalchandani Labs (BSE 541299)₹6.47−2.12%Healthcare Service Provider
At the end of the Mar 2026 quarter, Dr Lalchandani Labs' shareholders were: promoters 32.93%, public 67.07%. Promoter holding is up 1.75 percentage points from 31.18% a quarter earlier. 0.00% of promoter shares were pledged. It had 232 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 60.81% | 60.81% | 57.21% | 48.35% | 31.18% | 32.93% |
| Public | 39.19% | 39.19% | 42.79% | 51.65% | 68.82% | 67.07% |
| Promoter shares pledged | — | — | — | — | — | 0.00% |
| Number of shareholders | 158 | 164 | 180 | 245 | 205 | 232 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Arjan Lal Chandani | Promoter | 25.71% | — |
| Anuraag Gambhir | Public | 15.02% | — |
| Mohit Lal Chandani | Promoter | 6.04% | — |
| Harshpaul Singh Takkar | Public | 5.83% | — |
| Amit Charan | Public | 2.54% | — |
| Laxmipat Dudheria | Public | 2.54% | — |
| Luxmi Kant Gupta | Public | 2.12% | — |
| Suhith Pundalika Bangera | Public | 1.88% | — |
| Harsh Kapoor | Public | 1.75% | — |
| Statsol Research Llp | Public | 1.17% | — |
| Pavana | Public | 1.15% | — |
| Anchal Gupta | Promoter | 1.15% | — |
| Bhoomika Vikram Rao | Public | 1.10% | — |
| Mithun Securities Private Limited | Public | 1.03% | — |
| Sanath Kulalu | Public | 1.03% | — |
| Reetha Vikram | Public | 1.01% | — |
Promoters held 32.93% of Dr Lalchandani Labs at the end of the Mar 2026 quarter, down 27.88 percentage points from 60.81% a year earlier.
No. The Mar 2026 filing shows no pledged promoter shares.
Dr Lalchandani Labs had 232 shareholders at the end of the Mar 2026 quarter, against 164 a year earlier.
Anuraag Gambhir (Public) held 15.02% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.